- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07651527
Aging Well Together - 'Getting to Know You Better': Characterization of Health FACTors in People Advancing in AGE (BVE-FACTAGE)
BVE-FACTAGE: Aging Well Together - 'Getting to Know You Better': Characterization of Health FACTors in People Advancing in AGE
In order to implement effective actions to prevent the loss of autonomy in older adults, which has become a major issue, a crucial first step is to identify the conditions that influence it. Current approaches to health increasingly rely on a comprehensive and multidisciplinary vision, in line with so-called "socio-ecological" approaches, which argue that health is influenced by a wide range of interacting factors. However, these interdependencies and interactions are still poorly understood. It therefore seems necessary to move beyond the isolated analyses of risk factors carried out to date and adopt a holistic/systemic vision by examining both individual and environmental factors, as well as their interactions, which together can contribute to functional decline or the development of pathologies in older adults and those aging.
The aim of this study is to identify the relationships between intrapersonal and environmental factors, and their cumulative, moderating, and mediating effects on the health of older adults and those experiencing aging.
To this end, participants will be asked to complete a series of questionnaires and perform tests on various health-related dimensions. The evaluation criteria are: health, autonomy and quality of life, individual factors (health practices (e.g., physical activity), psychological characteristics (e.g., personal beliefs), socioeconomic status, etc.) and environmental factors (accessibility, living environment).
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Olivier GUERIN, Pr
- Numéro de téléphone: +33 0492034194
- E-mail: guerin.o@chu-nice.fr
Sauvegarde des contacts de l'étude
- Nom: Lyne DAUMAS
- E-mail: Lyne.DAUMAS@univ-cotedazur.fr
Lieux d'étude
-
-
-
Nice, France
- CHU de Nice - Hopital de Cimiez
-
Chercheur principal:
- Olivier GUERIN, Professor
-
Contact:
- Olivier GUERIN, Pr
- Numéro de téléphone: +33 0492034194
- E-mail: guerin.o@chu-nice.fr
-
Contact:
- Lyne DAUMAS
- E-mail: Lyne.DAUMAS@univ-cotedazur.fr
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Age 55 or older
- Affiliation with, or beneficiary of, a social security system
- No objection to the study
Exclusion Criteria:
- Individuals protected by law
- unable to participate in a clinical trial
- deprived of liberty
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: FACTAGE
|
Questionnaires and tests on health behaviors and health
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Autonomy
Délai: at baseline and at 6 months and at 12 months
|
Autonomy is assessed using the Instrumental Activities of Daily Living (IADL) Scale of Lawton. The scale comprises 8 items. The total score ranges from 0 to 8, with a higher score being better. |
at baseline and at 6 months and at 12 months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Care consumption, health behavior and psycho-socio-environmental characteristics
Délai: at baseline and at 6 and 12 months
|
The evaluation criteria will be, on the one hand, the same individual and environmental factors (e.g., personal beliefs, socio-economic status, accessibility, physical activity, diet) mentioned previously for the main objective, and on the other hand, the consumption of care (number and types of care).
|
at baseline and at 6 and 12 months
|
|
Measure Quality of life
Délai: at baseline and at 6 months and at 12 months
|
Quality of life is assessed using the EuroQol at 5 dimensions (EQ-5D) questionnaire. The scale comprises 5 items. Each item is scored from 1 "no problem" to 3 "severe problem". The total score ranges from 5 to 15 with higher score indicating a worse outcome. |
at baseline and at 6 months and at 12 months
|
|
Physical functional force (physical measure)
Délai: at baseline and at 6 months and at 12 months
|
: Physical functional force is assessed using the 5 sit-to-stand test wich consists of asking the participant to stand up and sit down from a chair 5 times as quickly as possible.
The outcome is the time taken to complete the test, and the unit of measurement is seconds.
|
at baseline and at 6 months and at 12 months
|
|
Sarcopenia (physical measure)
Délai: at baseline and at 6 months and at 12 months
|
Sarcopenia is assessed using the SARC-F questionnaire comprising 5 items assessing force, walk difficulties, stand up capacities, climb stairs capacities and fall.
Each item is scored from 0 to 2. The total score ranges from 0 to 10 with higher score indicating a worse outcome.
|
at baseline and at 6 months and at 12 months
|
|
Daily Physical activity Practice (physical behavioral lifestyle measure
Délai: at baseline and at 6 months and at 12 months
|
Daily Physical activity Practice is assessed using the Marshall questionnaire comprising 2 items.
The total score ranges from 0 to 8. A higher score means a higher level of physical activity.
The cut of 4 correspond to "sufficiently active".
|
at baseline and at 6 months and at 12 months
|
|
Subjective cognitive complaint (cognitive measure)
Délai: at baseline and at 6 and 12 months
|
Subjective cognitive complaint is assessed using items from the ICOPE cohort, regarding the presence and worsening (yes/no) of memory and orientation problems
|
at baseline and at 6 and 12 months
|
|
Body Mass Index (nutritional measure)
Délai: at baseline, 6 months later and 12 months
|
Body Mass Index corresponds to corresponds to weight (kg) divided by height (m) squared.
The unit is kg/m2.
|
at baseline, 6 months later and 12 months
|
|
Memory (cognitive measure)
Délai: at baseline, 6 months later and 12 months
|
Memory is assessed using a 3-word recall test.
Recalling a word is worth 1 point.
A higher score is better.
|
at baseline, 6 months later and 12 months
|
|
Cognitive attention (cognitive measure)
Délai: at baseline, 6 months later and 12 months
|
Cognitive attention is assessed consisting of asking to change the focus of attention.
Fewer errors result in a better score
|
at baseline, 6 months later and 12 months
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Comportement
- Activité motrice
- Qualité des soins de santé, accès et évaluation
- Techniques d'investigation
- Méthodes épidémiologiques
- Thérapeutique
- Collecte de données
- Mécanismes d'évaluation des soins de santé
- Qualité des soins de santé
- Santé publique
- Environnement et santé publique
- Contrôle du comportement
- Immobilisation
- Enquêtes et questionnaires
- Retenue, physique
Autres numéros d'identification d'étude
- 25-PP-15
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .